Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

PaperCitations, authors & open-access status

<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 4,477 citations, 2007 year and green oa status.

4,477
Citations
2007
Year
green
OA Status

Related on ScholarIQ

Jeffrey A. Engelman
Author
Pasi A. Jänne
Author
Science
Journal
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
PI3K/AKT/mTOR signaling in cancer
Topic
470M+ articles · free account